ADAMTS9 and neoplasm: ADAM metallopeptidase with thrombospondin type 1 motif, 9 (ADAMTS9) which has been characterized as a novel tumor suppressor gene, has been epigenetically silenced in lymph node metastases in nasopharyngeal carcinoma17.